Log in
Enquire now
‌

US Patent 10335404 Methods of treating cancer patients with farnesyltransferase inhibitors

Patent 10335404 was granted and assigned to Kura Oncology, Inc. on July, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Kura Oncology, Inc.
Kura Oncology, Inc.
Current Assignee
Kura Oncology, Inc.
Kura Oncology, Inc.
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10335404
Patent Inventor Names
Catherine Rose Scholz0
Antonio Gualberto0
Date of Patent
July 2, 2019
Patent Application Number
15844478
Date Filed
December 15, 2017
Patent Primary Examiner
‌
Peter J Reddig
Patent abstract

The present invention relates to the field of molecular biology and cancer biology. Specifically, the present invention relates to methods of treating a subject with a farnesyltransferase inhibitor (FTI) that include determining whether the subject is likely to be responsive to the FTI treatment based on genotyping and expression profiling of certain immunological genes and RAS mutation status in the subject.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10335404 Methods of treating cancer patients with farnesyltransferase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.